Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 5
1978 11
1979 14
1980 17
1981 26
1982 47
1983 44
1984 83
1985 57
1986 62
1987 51
1988 49
1989 43
1990 27
1991 44
1992 41
1993 28
1994 37
1995 26
1996 33
1997 29
1998 25
1999 35
2000 23
2001 21
2002 33
2003 23
2004 30
2005 37
2006 30
2007 26
2008 29
2009 25
2010 34
2011 34
2012 31
2013 21
2014 29
2015 29
2016 31
2017 25
2018 21
2019 23
2020 38
2021 33
2022 17
2023 20
2024 30
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,439 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of nadolol: A systematic review.
Kalsoom S, Zamir A, Rehman AU, Ashraf W, Imran I, Saeed H, Majeed A, Alqahtani F, Rasool MF. Kalsoom S, et al. J Clin Pharm Ther. 2022 Oct;47(10):1506-1516. doi: 10.1111/jcpt.13764. Epub 2022 Aug 30. J Clin Pharm Ther. 2022. PMID: 36040016 Review.
The bioavailability of nadolol was greatly reduced by the coadministration of green tea. Nadolol can be effectively removed by hemodialysis. ...WHAT IS NEW AND CONCLUSION: Since, there is no previous report of a systematic review on the PK of nadolol, the cur …
The bioavailability of nadolol was greatly reduced by the coadministration of green tea. Nadolol can be effectively removed by …
Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, Ma J. Pope E, et al. JAMA Pediatr. 2022 Jan 1;176(1):34-41. doi: 10.1001/jamapediatrics.2021.4565. JAMA Pediatr. 2022. PMID: 34747977 Free PMC article. Clinical Trial.
However, other less lipophilic beta-blockers, such as nadolol, may be preferable in individuals who experience propranolol unresponsiveness or adverse events. OBJECTIVE: To document the noninferiority and safety of oral nadolol compared with oral propranolol in infa …
However, other less lipophilic beta-blockers, such as nadolol, may be preferable in individuals who experience propranolol unresponsi …
Propranolol versus nadolol for treatment of pediatric subglottic hemangioma.
Yang W, Wolter NE, Cushing SL, Pope E, Wolter JK, Propst EJ. Yang W, et al. Int J Pediatr Otorhinolaryngol. 2021 May;144:110688. doi: 10.1016/j.ijporl.2021.110688. Epub 2021 Mar 21. Int J Pediatr Otorhinolaryngol. 2021. PMID: 33773428
METHODS: Single institution retrospective cohort study of pediatric SGH treated with propranolol or nadolol. RESULTS: Thirteen children (1 male, 12 female) with SGH were included: 6 were treated with propranolol (2.0-3.5 mg/kg/d) and 7 with nadolol (2.0-4.0 mg/kg/d) …
METHODS: Single institution retrospective cohort study of pediatric SGH treated with propranolol or nadolol. RESULTS: Thirteen childr …
Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
Colmenero Sendra M, Del Boz González J, Segura Palacios JM, Valladares Millán I, Eguiluz Solana M, de Troya Martín M. Colmenero Sendra M, et al. Actas Dermosifiliogr. 2024 Feb;115(2):215-217. doi: 10.1016/j.ad.2023.05.025. Epub 2023 Jun 23. Actas Dermosifiliogr. 2024. PMID: 37356545 Free article. English, Spanish. No abstract available.
Dose response to nadolol in congenital long QT syndrome.
Anys S, Arnaud M, Minois D, Rajalu A, Guyomarch B, Thollet A, Gourraud JB, Probst V. Anys S, et al. Heart Rhythm. 2021 Aug;18(8):1377-1383. doi: 10.1016/j.hrthm.2021.04.021. Epub 2021 Apr 24. Heart Rhythm. 2021. PMID: 33905813
OBJECTIVE: The purpose of this study was to explore dose response to nadolol on exercise test in LQTS patients in order to propose a more personalized therapeutic approach. ...CONCLUSION: Our study demonstrated a major variability of dose response to nadolol in pati …
OBJECTIVE: The purpose of this study was to explore dose response to nadolol on exercise test in LQTS patients in order to propose a …
Nadolol in essential tremor.
Koller WC. Koller WC. Neurology. 1983 Aug;33(8):1076-7. doi: 10.1212/wnl.33.8.1076. Neurology. 1983. PMID: 6348587 Clinical Trial.
Nadolol, 120 and 240 mg daily, reduced essential tremor in a placebo-controlled double-blind study. ...
Nadolol, 120 and 240 mg daily, reduced essential tremor in a placebo-controlled double-blind study. ...
"Nadolol in migrainous patients".
Pascual J. Pascual J. Headache. 1988 Oct;28(9):623-4. doi: 10.1111/j.1526-4610.1988.hed2809623.x. Headache. 1988. PMID: 3248940 No abstract available.
Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children.
von Alvensleben JC, LaPage MJ, Caruthers R, Bradley DJ. von Alvensleben JC, et al. Pediatr Cardiol. 2017 Mar;38(3):525-530. doi: 10.1007/s00246-016-1544-y. Epub 2016 Dec 19. Pediatr Cardiol. 2017. PMID: 27995288
We reviewed the clinical results of treating infant SVT with an extemporaneous preparation of nadolol. Retrospective cohort study of patients under 2 years old receiving nadolol for SVT at a single center. ...Oral nadolol suspension was a successful treatment …
We reviewed the clinical results of treating infant SVT with an extemporaneous preparation of nadolol. Retrospective cohort study of …
Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.
Lee WG, Murphy R, McCall JL, Gane EJ, Soop M, Tura A, Plank LD. Lee WG, et al. Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2859. Epub 2016 Nov 10. Diabetes Metab Res Rev. 2017. PMID: 27667324 Clinical Trial.
This study aimed to determine whether nonselective beta-blockade with nadolol impairs glucose metabolism in liver cirrhosis. METHODS: A randomized, double-blind, placebo-controlled crossover trial of nadolol in cirrhotic patients examined insulin sensitivity, dispos …
This study aimed to determine whether nonselective beta-blockade with nadolol impairs glucose metabolism in liver cirrhosis. METHODS: …
1,439 results